LexDanaLexDanabeta
Inventor

C. MICHAEL PHILBROOK

Inventor
US

Overview

2→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07BGeneral methods of organic chemistry25%
C07DHeterocyclic compounds25%
PatentTitleYear
12,527,737Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors202611,793,749Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to GENZYME CORP (2)· patent assignee history
2023–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENZYME CORP22023–2026
Locations
LocationPatentsSpan
US22023–2026